Trident Lifeline — 360° view

Trident Lifeline, a company in the Pharmaceuticals industry, reported revenue of ₹47 crore and net profit of ₹6.60 crore for the September 2026 quarter.

Trident Lifeline (BSE: TLL) closed at ₹406.05 on 20 Nov 2026, up 30.2% over the past year. Its market capitalisation is ₹486 crore and it trades at 21.5 times earnings.

Share price
₹406.05 (20 Nov 2026)
Market cap
₹486 Cr (20 Nov 2026)
P/E
21.47 (20 Nov 2026)
Revenue
₹47 Cr (September 2026 quarter)
Net profit
₹7 Cr (September 2026 quarter)
ROCE
21.1% (FY26)
ROE
22.6% (FY26)
Book value
₹95.2 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹442.00 / ₹229.95 (20 Nov 2026)
1-year return
30.2% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: TLL

Incorporated in 2014, Trident Lifeline Ltd manufactures and sells pharmaceuticals products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.